1-2 of 2
John Mendlein, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FT1050 (16,16-dimethyl Prostaglandin E2)-Enhanced Umbilical Cord Blood Accelerates Hematopoietic Engraftment After Reduced Intensity Conditioning and Double Umbilical Cord Blood Transplantation

Corey S. Cutler, MD, MPH, FRCPC, Daniel Shoemaker, PhD, Karen K. Ballen, MD, David Robbins, Caroline Desponts, PhD, Grace S. Kao, MD, Yi-Bin A. Chen, MD, Bimalangshu R. Dey, MD, Steven L. McAfee, MD, Edwin P Alyea, III, MD, John Koreth, MBBS, DPhil, Philippe Armand, MD, PhD, Vincent T Ho, MD, Haesook T Kim, PhD, Wolfram Goessling, MD, PhD, Trista E. North, Ph.D., Thomas R. Spitzer, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, John Mendlein, PhD, Pratik S. Multani, MD, MS
Journal: Blood
Blood (2011) 118 (21): 653.
https://doi.org/10.1182/blood.V118.21.653.653
Published: 2011
Journal Articles

Use of Genome-Wide Expression Analysis to Optimize An Ex Vivo clinical Protocol for 16,16-Dimethyl Prostaglandin E2 Enhancement of Umbilical Cord Blood In Hematopoietic Stem Cell Transplantation.

Caroline Desponts, PhD, David Robbins, Thuy Le, Annie Chi, Scott Thies, PhD, Myriam Armant, PhD, Corey Cutler, MD, MPH, FRCPC, John Mendlein, PhD, Paul Grayson, Pratik S. Multani, MD, MS, Daniel Shoemaker, PhD
Journal: Blood
Blood (2010) 116 (21): 1451.
https://doi.org/10.1182/blood.V116.21.1451.1451
Published: 2010